|
Pre-op |
3 months |
6 months |
12 months |
HHS |
|
|
|
|
HRA |
64.7 ± 8.1 |
92.5 ± 8.7* |
98.4 ± 2.5 |
99.1 ± 1.6 |
THA |
60.5 ± 10.1 |
98.5 ± 2.8 |
94.4 ± 4.9 |
99.9 ± 0.3 |
SF-36 PCS |
|
|
|
|
HRA |
38.8 ± 7.6 |
46.1 ± 7.1 |
46.4 ± 11.2 |
51.5 ±5.3 |
THA |
38.9 ± 10.5 |
46.7 ± 10.8 |
45.3 ± 13.2 |
46.4 ± 11.9 |
SF-36 MCS |
|
|
|
|
HRA |
63.2 ± 3.7 |
58.6 ± 7.2 |
60.6 ± 5.3 |
58.3 ± 2.5 |
THA |
58.5 ± 8.2 |
57.1 ± 6.0 |
57.3 ± 4.8 |
56.0 ± 4.1 |
UCLA |
|
|
|
|
HRA |
5.2 ± 1.1 |
6.9 ± 1.2 |
7.7 ± 1.0* |
8.0 ± 1.4 |
THA |
5.7 ± 1.7 |
7.1 ± 1.3 |
7.0 ± 1.4 |
7.6 ± 1.4 |
*difference between HRA and THA significant at P<0.05. |
|